Patient-Specific Custom Implants for Spine and Sacral Tumor Reconstruction

Disclosure(s):

Matthew Goodwin, MD: AO Spine North America: Board Member/Officer/Trustee (Ongoing); Astra Zeneca, Bayer, Black Diamond, Boehringer Ingelheim, Boston Pharmaceuticals, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Karyopharm, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Servi: Stock Options (Ongoing); BioNTech: Ownership Interest (Ongoing); Johnson & Johnson: Stock Options (Ongoing); KAIA: Stock Options (Ongoing); Kendall Hunt Publishing: Royalty Recipient (Ongoing); Moderna: Stock Options (Ongoing); NASS: Board Member/Officer/Trustee (Ongoing); Pfizer: Stock Options (Ongoing); ROM3: Stock Options (Ongoing)